← Leaderboards
Hamid Band
Brigham And Women'S Hospital
$15,640,616
Attributed
$15,640,616
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,640,616 · 11
By mechanism
R01$14,611,263 · 7
P30$638,167 · 3
R21$391,186 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Samuel C Mok$7,260,442
- Erika Heidi Noss$728,608
Others in their field
Top investigators on “Protein Tyrosine Kinase”
- Nicholas K Tonks · Cold Spring Harbor Laboratory$26,224,874
- Benjamin G. Neel · New York University School Of Medicine$18,704,735
- Thomas J. Kipps · University Of California San Diego$18,433,055
- Mark A. Lemmon · Yale University$18,236,006
- Arthur Weiss · University Of California, San Francisco$17,157,066
- Satya P. Kunapuli · Temple University$16,655,693
Research focus
Protein Tyrosine KinaseMolecularBiochemicalCellsSignal TransductionMalignant NeoplasmsUbiquitinReceptorInsightMemberResponseBaseCell ProliferationProteinsEpidermal Growth Factor ReceptorTumorigenesisFamilyLysosomesTumorBiologicalPlayTraffickingMediatingLigands
Grant awards (73)
Co-targeting IGF-1R and Glutaminase in Ewing Sarcoma$391,186
R21 · FY2025 · CA · contact PI
Cancer Biology Program$68,738
P30 · FY2025 · CA · contact PI
Cancer Biology Program$63,652
P30 · FY2024 · CA · contact PI
Cancer Biology Program$63,650
P30 · FY2023 · CA · contact PI
Cancer Biology Program$63,650
P30 · FY2022 · CA · contact PI
Cancer Biology Program$63,478
P30 · FY2021 · CA · contact PI
Molecular and Biochemical Etiology (MBE)$63,311
P30 · FY2020 · CA · contact PI
Molecular and Biochemical Etiology (MBE)$63,311
P30 · FY2019 · CA · contact PI
Molecular and Biochemical Etiology (MBE)$64,409
P30 · FY2018 · CA · contact PI
Molecular and Biochemical Etiology (MBE)$66,915
P30 · FY2017 · CA · contact PI
Molecular and Biochemical Etiology (MBE)$57,053
P30 · FY2016 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$269,290
R01 · FY2015 · CA · contact PI
Targeting Endocytic Recycling of EGF Receptor in Cancer$279,739
R01 · FY2014 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$261,212
R01 · FY2014 · CA · contact PI
Targeting Endocytic Recycling of EGF Receptor in Cancer$46,156
R01 · FY2014 · CA · contact PI
Targeting Endocytic Recycling of EGF Receptor in Cancer$271,088
R01 · FY2013 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$253,133
R01 · FY2013 · CA · contact PI
Targeting Endocytic Recycling of EGF Receptor in Cancer$40,596
R01 · FY2013 · CA · contact PI
Molecular Control of EGF Receptor Down-Regulation$328,717
R01 · FY2012 · CA · contact PI
Targeting Endocytic Recycling of EGF Receptor in Cancer$288,391
R01 · FY2012 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$269,290
R01 · FY2012 · CA · contact PI
Molecular Control of EGF Receptor Down-Regulation$328,717
R01 · FY2011 · CA · contact PI
Targeting Endocytic Recycling of EGF Receptor in Cancer$288,391
R01 · FY2011 · CA · contact PI
ErbB2 Downregulation Through HSP90 Inhibition$270,921
R01 · FY2011 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$269,290
R01 · FY2011 · CA · contact PI
Molecular Control of EGF Receptor Down-Regulation$338,884
R01 · FY2010 · CA · contact PI
Targeting Endocytic Recycling of EGF Receptor in Cancer$297,310
R01 · FY2010 · CA · contact PI
ErbB2 Downregulation Through HSP90 Inhibition$279,300
R01 · FY2010 · CA · contact PI
Molecular Control of EGF Receptor Down-Regulation$348,002
R01 · FY2009 · CA · contact PI
Molecular Control of EGF Receptor Down-Regulation$329,014
R01 · FY2009 · CA · contact PI
ErbB2 Downregulation Through HSP90 Inhibition$279,300
R01 · FY2009 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$266,570
R01 · FY2009 · CA · contact PI
Molecular Control of EGF Receptor Down-Regulation$312,819
R01 · FY2008 · CA · contact PI
Endosomal ErbB Receptor and Src Signaling in Cancer$281,996
R01 · FY2008 · CA · contact PI
ErbB2 Downregulation Through HSP90 Inhibition$279,300
R01 · FY2008 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$260,080
R01 · FY2008 · CA · contact PI
MOLECULAR CONTROL OF EGF RECEPTOR DOWN-REGULATION$280,985
R01 · FY2007 · CA · contact PI
ErbB2 Downregulation Through HSP90 Inhibition$239,610
R01 · FY2007 · CA · contact PI
Endosomal ErbB Receptor and Src Signaling in Cancer$195,494
R01 · FY2007 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$173,460
R01 · FY2007 · CA · contact PI
PDGF Receptor Regulation by CBL$154,445
R01 · FY2007 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$102,177
R01 · FY2007 · CA · contact PI
Endosomal ErbB Receptor and Src Signaling in Cancer$99,960
R01 · FY2007 · CA · contact PI
PDGF Receptor Regulation by CBL$61,740
R01 · FY2007 · CA · contact PI
ErbB2 Downregulation Through HSP90 Inhibition$49,190
R01 · FY2007 · CA · contact PI
MOLECULAR CONTROL OF EGF RECEPTOR DOWN-REGULATION$39,690
R01 · FY2007 · CA · contact PI
MOLECULAR CONTROL OF EGF RECEPTOR DOWN-REGULATION$330,252
R01 · FY2006 · CA · contact PI
Endosomal ErbB Receptor and Src Signaling in Cancer$304,278
R01 · FY2006 · CA · contact PI
Tyrosine Kinase Regulation Via Protein Degradation$283,869
R01 · FY2006 · CA · contact PI
PDGF Receptor Regulation by CBL$222,642
R01 · FY2006 · CA · contact PI
MOLECULAR CONTROL OF EGF RECEPTOR DOWN-REGULATION$338,200
R01 · FY2005 · CA
Endosomal ErbB Receptor and Src Signaling in Cancer$311,600
R01 · FY2005 · CA
Tyrosine Kinase Regulation Via Protein Degradation$290,700
R01 · FY2005 · CA
PDGF Receptor Regulation by CBL$228,000
R01 · FY2005 · CA
MOLECULAR CONTROL OF EGF RECEPTOR DOWN-REGULATION$318,561
R01 · FY2004 · CA
Endosomal ErbB Receptor and Src Signaling in Cancer$311,600
R01 · FY2004 · CA
TYROSINE KINASE REGULATION VIA PROTEIN DEGRADATION$242,100
R01 · FY2004 · CA
PDGF Receptor Regulation by CBL$207,000
R01 · FY2004 · CA
MOLECULAR CONTROL OF EGF RECEPTOR DOWN-REGULATION$2,979
R01 · FY2004 · CA
TYROSINE KINASE REGULATION VIA PROTEIN DEGRADATION$273,600
R01 · FY2003 · CA
MOLECULAR CONTROL OF EGF RECEPTOR DOWN-REGULATION$243,565
R01 · FY2003 · CA
PDGF Receptor Regulation by CBL$152,000
R01 · FY2003 · CA
MOLECULAR CONTROL OF EGF RECEPTOR DOWN-REGULATION$141,360
R01 · FY2003 · CA
PDGF Receptor Regulation by CBL$107,500
R01 · FY2003 · CA
TYROSINE KINASE REGULATION VIA PROTEIN DEGRADATION$31,500
R01 · FY2003 · CA
TYROSINE KINASE REGULATION VIA PROTEIN DEGRADATION$305,100
R01 · FY2002 · CA
FUNCTIONAL DISSECTION OF CBLS TRANSFORMING DOMAIN$243,166
R01 · FY2002 · CA
TYROSINE KINASE REGULATION VIA PROTEIN DEGRADATION$305,100
R01 · FY2001 · CA
REGULATING TYROSINE KINASE SIGNALS IN BREAST CANCER$257,565
R01 · FY2001 · CA
FUNCTIONAL DISSECTION OF CBLS TRANSFORMING DOMAIN$237,536
R01 · FY2001 · CA
TYROSINE KINASE REGULATION VIA PROTEIN DEGRADATION$305,100
R01 · FY2000 · CA
REGULATING TYROSINE KINASE SIGNALS IN BREAST CANCER$250,065
R01 · FY2000 · CA
FUNCTIONAL DISSECTION OF CBLS TRANSFORMING DOMAIN$232,068
R01 · FY2000 · CA